Bertrand Loy, Director at HARVARD BIOSCIENCE INC (HBIO), bought 9,291 shares at $3.41 ($32K) on 2022-08-26, disclosed to the SEC on 2022-08-29.
Open-market purchase of $32k HBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ENTG | SELL | 2026-02-26 | $15.2M | — | Filing → |
| ENTG | SELL | 2026-02-04 | $7.8M | — | Filing → |
| ENTG | SELL | 2025-12-03 | $8.8M | — | Filing → |